R. Fleischmann

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

R. Fleischmann, Bradley M. Kerr, Li‐Tain Yeh et al. · Lara D. Veeken · 2014 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Tenidap in rheumatoid arthritis a 24‐week double‐blind comparison with hydroxychloroquine‐plus‐piroxicam, and piroxicam alone

Warren D. Blackburn, H. Malin Prupas, Joel C. Silverfield et al. · Arthritis & Rheumatism · 1995 · 44 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies

R. Fleischmann, J. Wollenhaupt, Liza Takiya et al. · RMD Open · 2017 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis

Paul Emery, Désirée van der Heijde, Mikkel Østergaard et al. · Annals of the Rheumatic Diseases · 2011 · 40 citations · Full text

Medicine, Clinical Sciences, Radiology +12